Touchstone International Medical Science Co., Ltd. (688013.SS)
CNY 20.13
(3.76%)
CNY 20.13
(3.76%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 47.31 Million CNY | 9.53% |
| 2022 | 43.19 Million CNY | 4.29% |
| 2021 | 41.41 Million CNY | 18.52% |
| 2020 | 34.94 Million CNY | -16.8% |
| 2019 | 42 Million CNY | 81.6% |
| 2018 | 23.13 Million CNY | 66.34% |
| 2017 | 13.9 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 17.49 Million CNY | 54.15% |
| 2024 Q3 | 13.9 Million CNY | -20.57% |
| 2024 Q1 | 11.35 Million CNY | -41.93% |
| 2023 Q3 | 6.52 Million CNY | -56.2% |
| 2023 FY | 47.31 Million CNY | 9.53% |
| 2023 Q4 | 19.54 Million CNY | 199.72% |
| 2023 Q2 | 14.88 Million CNY | 27.27% |
| 2023 Q1 | 11.69 Million CNY | 2.6% |
| 2022 Q3 | 12.66 Million CNY | 6.86% |
| 2022 Q2 | 11.85 Million CNY | 63.11% |
| 2022 Q1 | 7.26 Million CNY | 43.36% |
| 2022 FY | 43.19 Million CNY | 4.29% |
| 2022 Q4 | 11.4 Million CNY | -9.99% |
| 2021 Q1 | 12.93 Million CNY | 45.78% |
| 2021 Q4 | 5.06 Million CNY | -55.86% |
| 2021 FY | 41.41 Million CNY | 18.52% |
| 2021 Q3 | 11.48 Million CNY | -3.69% |
| 2021 Q2 | 11.92 Million CNY | -7.84% |
| 2020 Q3 | 9.78 Million CNY | -4.89% |
| 2020 Q1 | 6 Million CNY | -18.78% |
| 2020 Q2 | 10.28 Million CNY | 71.17% |
| 2020 FY | 34.94 Million CNY | -16.8% |
| 2020 Q4 | 8.87 Million CNY | -9.25% |
| 2019 FY | 42 Million CNY | 81.6% |
| 2019 Q3 | 13.13 Million CNY | -8.59% |
| 2019 Q2 | 14.37 Million CNY | 102.45% |
| 2019 Q1 | 7.09 Million CNY | 0.0% |
| 2019 Q4 | 7.39 Million CNY | -43.7% |
| 2018 FY | 23.13 Million CNY | 66.34% |
| 2017 FY | 13.9 Million CNY | 0.0% |